Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Bacterial Infections and Mycoses

  Free Subscription


08.06.2026

4 Antimicrob Agents Chemother
5 Clin Infect Dis
1 Curr Microbiol
3 Diagn Microbiol Infect Dis
10 Eur J Clin Microbiol Infect Dis
2 Infect Immun
3 J Antimicrob Chemother
1 J Infect Dis
1 J Med Chem
1 PLoS Med
4 PLoS One
1 PLoS Pathog
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. BARKER KS, Santana DJ, Zhang Q, Peters TL, et al
    Correction for Barker et al., "Mutations in TAC1B drive CDR1 and MDR1 expression and azole resistance in Candida auris".
    Antimicrob Agents Chemother. 2026 Jun 4:e0150725. doi: 10.1128/aac.01507.
    PubMed        

  2. CALISE DG, Michaelis ML, Park SC, Wagner AS, et al
    ZfpA-regulated chitin synthesis in Aspergillus fumigatus hyphae determines fungicidal tip lysis by FksA-targeting antifungals.
    Antimicrob Agents Chemother. 2026 Jun 4:e0176925. doi: 10.1128/aac.01769.
    PubMed         Abstract available

  3. WIEDERHOLD NP, Patterson HP, Sanders C, Canete-Gibas C, et al
    Manogepix demonstrates potent in vitro activity against Aspergillus, Coccidioides, Scopulariopsis/Microascus, Rasamsonia, and Purpureocillium species, including strains with in vitro resistance to other antifungals.
    Antimicrob Agents Chemother. 2026 Jun 4:e0047626. doi: 10.1128/aac.00476.
    PubMed         Abstract available

  4. YUSUFF H, Gadsby J, Isgro G, Zochios V, et al
    Time-varying voriconazole clearance during extracorporeal membrane oxygenation.
    Antimicrob Agents Chemother. 2026;70:e0009826.
    PubMed         Abstract available


    Clin Infect Dis

  5. HOPKINS J, Tosas-Auguet O, Waithira N, Painter C, et al
    Mortality and Length of Stay Associated With Community-Acquired Escherichia coli and Staphylococcus aureus Bloodstream Infections: An Observational Study in 9 Low- and Middle-Income Countries.
    Clin Infect Dis. 2026 Jun 2:ciag275. doi: 10.1093.
    PubMed         Abstract available

  6. NGUYEN ATK, Paterson DL, Mo Y, Ezure Y, et al
    Efficacy and Safety of Newer Antibiotics Versus Generic Antibiotics for Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available

  7. MANESH A, Aslan AT, Mohan George M, Sulaiman H, et al
    Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available

  8. PATERSON DL, Melnick D, Dane A, Goldberger M, et al
    Considerations in Designing Clinical Trials of Novel Antibacterial Agents Using a Superiority Design.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available

  9. PATERSON DL
    Advancing Clinical Evidence in Infectious Diseases: An Infectious Diseases Clinical Trials Network for Asia, the "Antimicrobial Resistance Hot Zone".
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available


    Curr Microbiol

  10. MATIOLA DC, da Rosa Monte Machado G, Israel GE, Fuentefria AM, et al
    Evaluation of Adhesion and Co-culture Efficacy Assays of Antifungals and Chlorhexidine Against Acanthamoeba and Candida Species Associated with Severe Infectious Keratitis.
    Curr Microbiol. 2026;83:401.
    PubMed         Abstract available


    Diagn Microbiol Infect Dis

  11. CEBULLA C, Hamdan A, Poonawala H, Alsoubani M, et al
    Species-level reporting of Coagulase-negative staphylococci with MALDI-TOF does not impact clinical outcomes.
    Diagn Microbiol Infect Dis. 2026;116:117479.
    PubMed         Abstract available

  12. KHALID T, Kucharova M, Mokhira B, Toirov B, et al
    Zoonotic diseases and their impact on human and animal health.
    Diagn Microbiol Infect Dis. 2026;116:117460.
    PubMed         Abstract available

  13. VAN PRAET JT, Van Acker L, Van den Berghe I, Vanhee M, et al
    Acute pulmonary histoplasmosis in a Belgian traveller returning from Suriname diagnosed with NGS: a case report.
    Diagn Microbiol Infect Dis. 2026;116:117461.
    PubMed         Abstract available


    Eur J Clin Microbiol Infect Dis

  14. SARICAOGLU EM, Akdemir I, Saldere EH, Ozugergin A, et al
    Endovascular management of a non-typhoidal Salmonella-associated mycotic pseudoaneurysm of the iliac artery: a case report.
    Eur J Clin Microbiol Infect Dis. 2026;45:1471-1475.
    PubMed         Abstract available

  15. ZOCCHE G, Lewis RE, Bianco G, Tascini C, et al
    In vitro interactions of sulbactam/durlobactam in combination with meropenem, ceftazidime/avibactam, piperacillin/tazobactam, cefiderocol and fosfomycin against carbapenem-resistant Acinetobacter baumannii (CRAB) clinical isolates.
    Eur J Clin Microbiol Infect Dis. 2026;45:1483-1489.
    PubMed         Abstract available

  16. MELLON G, Ciotti C, Kimseng H, Braille A, et al
    An unusual cross-transmission of carbapenem-resistant Acinetobacter baumannii: when the endoscope isn't the only culprit.
    Eur J Clin Microbiol Infect Dis. 2026;45:1501-1505.
    PubMed         Abstract available

  17. MUNTAHA ST, Khan GN, Khan I, Hassan M, et al
    Genomic insights into phage SGP007 reveal a potent therapeutic candidate for targeted control of salmonellosis in poultry.
    Eur J Clin Microbiol Infect Dis. 2026;45:1307-1321.
    PubMed         Abstract available

  18. HAQ K, Figgitt M, Lee D, Spencer J, et al
    Isolation and characterisation of a novel Stenotrophomonas maltophilia phage vB_SmaS_BCU-1 with evaluation of mammalian cell safety.
    Eur J Clin Microbiol Infect Dis. 2026;45:1333-1348.
    PubMed         Abstract available

  19. INIGO-MARTINEZ J, Sanz-Moreno JC, Martin-Martinez F, Garrido-Estepa M, et al
    Persistence of vaccine-induced serotype-related pathology in invasive pneumococcal disease in children. Community of Madrid, 2007-2024.
    Eur J Clin Microbiol Infect Dis. 2026;45:1365-1377.
    PubMed         Abstract available

  20. LUND HM, Brandal LT, Odeskaug LE, Lange H, et al
    Outbreak of Salmonella Typhimurium ST19 linked to passerine birds and cats in Norway, March to July 2024.
    Eur J Clin Microbiol Infect Dis. 2026;45:1401-1408.
    PubMed         Abstract available

  21. MA S, Kong W, Duan M, Mo F, et al
    Comparative evaluation of BacT/ALERT PF Plus and PF pediatric blood culture bottles: A dual in vitro and clinical retrospective study.
    Eur J Clin Microbiol Infect Dis. 2026;45:1461-1469.
    PubMed         Abstract available

  22. DEMIR M, Ocakli AI, Tanriverdi ES, Hazirolan G, et al
    Evaluation of resistance mechanisms and susceptibility testing in Enterococcus spp.: implications of vancomycin-variable isolates and optrA-mediated resistance.
    Eur J Clin Microbiol Infect Dis. 2026 Jun 2. doi: 10.1007/s10096-026-05556.
    PubMed         Abstract available

  23. MATHIESEN I, Haldorsen BC, Smabrekke L, Matuschek E, et al
    Performance of disk diffusion and MIC gradient tests in tigecycline susceptibility testing of enterococci: a Nordic multicentre study.
    Eur J Clin Microbiol Infect Dis. 2026 Jun 4. doi: 10.1007/s10096-026-05557.
    PubMed         Abstract available


    Infect Immun

  24. SEBASTIAN CC, Boone R, Birket SE, Kiedrowski MR, et al
    Increased low-molecular-weight mucins in muco-obstructive airway disease limit Staphylococcus aureus growth.
    Infect Immun. 2026 Jun 4:e0069325. doi: 10.1128/iai.00693.
    PubMed         Abstract available

  25. FENG X, Cao T, Jia X, Jia Z, et al
    Chlamydia pneumoniae facilitates its development by recruiting PI4P to inclusion bodies via the Cpn0308-ACBD3-PI4KB pathway.
    Infect Immun. 2026 Jun 4:e0058025. doi: 10.1128/iai.00580.
    PubMed         Abstract available


    J Antimicrob Chemother

  26. LI G, El-Deeb IM, Whyte HG, Blaskovich MAT, et al
    Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus.
    J Antimicrob Chemother. 2026;81:dkag186.
    PubMed         Abstract available

  27. TUROWSKI P, Cremanns M, Pfennigwerth N, Gatermann SG, et al
    Influence of a putative TonB-dependent receptor on cefiderocol susceptibility in clinical Enterobacter hormaechei isolates.
    J Antimicrob Chemother. 2026;81:dkag193.
    PubMed         Abstract available

  28. LASRY D, Harrison LB, Bamba R, Corsini R, et al
    In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA).
    J Antimicrob Chemother. 2026;81:dkag182.
    PubMed         Abstract available


    J Infect Dis

  29. GIBERT C, Bigot J, Brissot E, Banet A, et al
    Clinical and analytical evaluation of a commercial Aspergillus fumigatus real-time PCR assay for the diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies.
    J Infect Dis. 2026 May 31:jiag280. doi: 10.1093.
    PubMed         Abstract available


    J Med Chem

  30. URBANOWICZ KA, Marek-Urban PH, Wrochna K, Rogalska M, et al
    C-BODIPY Dyads Based on Fused-Ring Organoboron Scaffolds for Efficient Photodynamic Therapy Targeting Candida albicans Yeast and Biofilms.
    J Med Chem. 2026 Jun 1. doi: 10.1021/acs.jmedchem.6c00280.
    PubMed         Abstract available


    PLoS Med

  31. LIU YE, Bampi JVB, Arthur RF, Salindri AD, et al
    Comparative impacts and cost-effectiveness of tuberculosis systematic screening strategies in prisons in Brazil, Colombia, and Peru: A mathematical modeling study.
    PLoS Med. 2026;23:e1004739.
    PubMed         Abstract available


    PLoS One

  32. NASINGHE E, Musinguzi D, Takuwa M, Kamulegeya R, et al
    Tuberculosis in households with infectious cases in Kampala city: Harnessing health data science for new insights on an ancient disease with persistent, unresolved problems.
    PLoS One. 2026;21:e0348823.
    PubMed         Abstract available

  33. PIVARD M, Bar J, Demeter T, Mairpady Shambat S, et al
    Staphylococcus aureus agr-type vs genetic background: molecular signatures determining differential metabolism and virulence potential.
    PLoS One. 2026;21:e0350108.
    PubMed         Abstract available

  34. WANG W, Zhang X, Yu H, Wang Z, et al
    Establishment and application of a quadruple target real-time PCR assay for detecting Yersinia pestis.
    PLoS One. 2026;21:e0350660.
    PubMed         Abstract available

  35. HARLEY BK, Ben IO, Asamoah TD, Amengor CDK, et al
    Potent and broad-spectrum anti-Candida activity of 6alpha-(3'-methoxy-4'-hydroxybenzoyl)-lup-20(29)-ene-3-one, a triterpenoid from Paullinia pinnata.
    PLoS One. 2026;21:e0350399.
    PubMed         Abstract available


    PLoS Pathog

  36. LAU LS, Lichtenberger S, Taira CL, Klein BS, et al
    Homotypic interactions between SLAMF1 receptors on innate T cells and neutrophils regulate killing of fungi.
    PLoS Pathog. 2026;22:e1014282.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  37. WU X, Jin L, Wang Q, Wang R, et al
    TadA-mediated A-to-I mRNA editing rewires redox metabolism to promote dominance of epidemic Klebsiella pneumoniae clones.
    Proc Natl Acad Sci U S A. 2026;123:e2536397123.
    PubMed         Abstract available

  38. HSIEH YP
    Potassium controls skin adaptation in Candida auris.
    Proc Natl Acad Sci U S A. 2026;123:e2611972123.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum